🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In January the PROTID project kicked off with a meeting hosted by partner NIMR MMRC

Read our first publication on the importance of the PROTID trial for the prevention and management of combined TB and DM in IJTLD: researchgate.net/publication/34…

Dr. Sweetness from KCMC Tanzania presenting in the PROTID research meeting: how can we improve quality of diabetes care?

Find out everything about the PROTID project on our brand-new website: protid-africa.com #EndTB #DiabetesAwareness @KilimanjaroChr2 NIMR Mbeya Radboudumc King's College London University of Otago St George's, University of London (1752-2024) Kilimanjaro Clinical Research Institute Lubaga Hospital @MakerereU

LAST REMINDER Deadline for applications 28 October 2020 Full details on the AREF website bit.ly/30pYNrR

Tomorrow is #WorldDiabetesDay #DidYouKnow: More than half of the 15.9 million people living with diabetes in the African Region🌍 don’t know they have it.

On November 14th 2020, World Diabetes Day, PROTID was launched in Uganda! @KilimanjaroChr2 NIMR Mbeya Radboudumc King's College London University of Otago St George's, University of London (1752-2024) Kilimanjaro Clinical Research Institute Lubaga Hospital @MakerereU EDCTP protid-africa.com/protid-launche…

Reinout van Crevel and Julia Critchley have recently published a paper in Tropical Medicine and Infectious Disease MDPI titled 'The Interaction of #Diabetes and #Tuberculosis: Translating Research to Policy'.

This #WorldTBDay’s theme is ‘clock is ticking’. It's time to translate commitments to #endTB into urgent action. #Diabetes is a recognized re-emerging risk & challenge to #TB control, as individuals with diabetes have 3 times the risk of developing TB. youtu.be/kpG3hz5UtUY

Today we mark #WorldTuberculosisDay with Prof @helen_ayles who leads the EDCTP funded TREATS project and highlights the importance of TB diagnosis in times of COVID to #EndTB #TheClockIsTicking @zambartresearch

Happy to work together with great partners in the fight against #TB, in particular in the #diabetes population! #WorldTBDay #TheClockIsTicking @KilimanjaroChr2 NIMR Mbeya Radboudumc King's College London University of Otago St George's, University of London (1752-2024) Kilimanjaro Clinical Research Institute Lubaga Hospital @MakerereU

Tomorrow we will be speaking at the World Health Organization (WHO) Technical Consultation on Innovative Clinical Trial Designs for the Evaluation of New TB Preventive Treatment about #PROTID and our upcoming trial! #Tuberculosis #EDCTP #diabetes

We've recently expanded our publications list with a new publication titled '#Tuberculosis preventive therapy for people with #diabetes mellitus'. You can find more information on our #PROTID website at protid-africa.com/publications/

🆕 WHO's Global TB Report reveals deaths from #tuberculosis rise for the first time in more than a decade due to the #COVID19 pandemic. 1.5 million people died in 2020 & the number will continue to rise unless urgent action is taken 👉bit.ly/3FMmRIl #EndTB

Our systematic review on Tuberculosis risk among people with diabetes mellitus in Sub-Saharan Africa by Ilja Obels, Sandra Ninsiima, Julia A. Critchley and Peijue Huangfu has been accepted into the TMIH Journal! #TB #DM

See our update on first PROTID study participants recruited at: protid-africa.com/first-particip…

Congratulations to Ms. Willyhelmina Olomi, a PhD candidate within the PROTID Africa trial consortium, who has been selected to receive the Society for Clinical Trials (SCT) 2023 Equity, Diversity, and Inclusion (ED&I) Early-Career Award SCTorg NIMR Mbeya Willyhelmina Olomi